Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | Common Stock | Options Exercise | $130K | +600 | +3.55% | $216.45 | 17.5K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$4.76K | -22 | -0.13% | $216.45 | 17.5K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $80.5K | +372 | +2.13% | $216.45 | 17.9K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$37.9K | -175 | -0.98% | $216.45 | 17.7K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $87.7K | +405 | +2.29% | $216.45 | 18.1K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$41.3K | -191 | -1.06% | $216.45 | 17.9K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $124K | +575 | +3.21% | $216.45 | 18.5K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$58.7K | -271 | -1.47% | $216.45 | 18.2K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Options Exercise | $320K | +1.48K | +8.12% | $216.45 | 19.7K | Mar 1, 2024 | Direct | |
transaction | AVY | Common Stock | Tax liability | -$150K | -695 | -3.53% | $216.45 | 19K | Mar 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AVY | 2024 MSU Award | Award | $0 | +1.8K | $0.00 | 1.8K | Mar 1, 2024 | Common Stock | 1.8K | $0.00 | Direct | F1 | |
transaction | AVY | 2024 PU Award | Award | $0 | +2.18K | $0.00 | 2.18K | Mar 1, 2024 | Common Stock | 2.18K | $0.00 | Direct | F2 | |
transaction | AVY | 2020 MSU Award | Options Exercise | $0 | -600 | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 600 | $0.00 | Direct | F3 |
transaction | AVY | 2021 MSU Award | Options Exercise | $0 | -372 | -58.31% | $0.00 | 266 | Mar 1, 2024 | Common Stock | 372 | $0.00 | Direct | F4 |
transaction | AVY | 2022 MSU Award | Options Exercise | $0 | -405 | -32.74% | $0.00 | 832 | Mar 1, 2024 | Common Stock | 405 | $0.00 | Direct | F5 |
transaction | AVY | 2023 MSU Award | Options Exercise | $0 | -575 | -24.91% | $0.00 | 1.73K | Mar 1, 2024 | Common Stock | 575 | $0.00 | Direct | F6 |
transaction | AVY | 2021 PU Award | Options Exercise | $0 | -1.48K | -100% | $0.00* | 0 | Mar 1, 2024 | Common Stock | 1.48K | $0.00 | Direct | F7 |
Id | Content |
---|---|
F1 | Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
F2 | Performance units (PUs) vest, at the end of fiscal year 2026, provided certain performance objectives are met as determined by the Compensation Committee in February 2027. Each PU represents a contingent right to receive one share of common stock. |
F3 | Shares reflect the vesting of the fourth tranche of MSUs granted in February 2020 at 180% of target based on our absolute total stockholder return in excess of 10% during the 2020-2023 performance period, plus dividend equivalents accrued during the period. |
F4 | Shares reflect the vesting of the third tranche of MSUs granted in March 2021 at 134% of target based on our absolute total stockholder return in excess of 10% during the 2021-2023 performance period, plus dividend equivalents accrued during the period. |
F5 | Shares reflect the vesting of the second tranche of MSUs granted in March 2022 at 94% of target based on our absolute total stockholder return during the 2022-2023 performance period, plus dividend equivalents accrued during the period. |
F6 | Shares reflect the vesting of the first tranche of MSUs granted in March 2023 at 98% of target based on our absolute total stockholder return during the 2023 performance period, plus dividend equivalents accrued during the period. |
F7 | Shares reflect the vesting of PUs granted in March 2021 at 123% of target, based 75% on the cumulative economic value added of RBIS (now Solutions Group) and 25% on our relative total stockholder return. |